What does this research mean for the field?

Arrhythmogenic mitral valve prolapse is a heterogeneous syndrome driven by mechanical stress and myocardial fibrosis, requiring integrated risk stratification to identify the specific subset of patients at risk for malignant ventricular arrhythmias and sudden cardiac death. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.SUPPORTS_CONSENSUS.

March 3, 2026Kardiologia PolskaOpen Access

Arrhythmogenic MVP is a complex syndrome characterized by clinical, anatomical, myocardial, and electrical features (including bileaflet prolapse, mitral annular disjunction, and myocardial fibrosis) that requires integrated risk stratification.

View Full Paper

Ask AI

Bookmark

Why the study?

Arrhythmogenic MVP represents a heterogeneous syndrome with risk of malignant ventricular arrhythmias and sudden cardiac death, underscoring the need to summarize recent progress, expert recommendations, and registry data.

Design

State-of-the-Art Review

Authors

PWPaulina Wejner-Mik HMHector I Michelena KMKatarzyna Mizia-Stec

Discussion

Member takes

Overview

Prompts detailed echo/ECG phenotyping to stratify SCD risk in MVP; extends recognition of this heterogeneous syndrome beyond isolated prolapse.

Key Points

Ventricular arrhythmias are a significant risk in mitral valve prolapse, especially in a subset of patients.
Research shows that arrhythmic risk remains post-surgery for mitral regurgitation due to existing myocardial substrate.
Clinical characteristics, like mitral annular disjunction and myocardial fibrosis, are key indicators of arrhythmogenic MVP.
Registry data emphasize the need for detailed echocardiographic evaluation to identify true arrhythmogenic MVP cases.

Structured PICO

Population

Patients with mitral valve prolapse (MVP) and arrhythmogenic MVP

Arrhythmogenic MVP represents a heterogeneous disease spectrum requiring detailed echocardiographic and electrocardiographic assessment to identify the subset of patients at risk for malignant ventricular arrhythmias and sudden cardiac death.

Cite This Study

Wejner-Mik et al. (2026) studied this question.

synapsesocial.com/papers/69a75b95c6e9836116a23210 https://doi.org/10.33963/v.phj.110914

View Full Paper

Ask AI

Bookmark

March 3, 2026Kardiologia PolskaOpen Access

Arrhythmogenic MVP is a complex syndrome characterized by clinical, anatomical, myocardial, and electrical features (including bileaflet prolapse, mitral annular disjunction, and myocardial fibrosis) that requires integrated risk stratification.

View Full Paper

Ask AI

Bookmark

Why the study?

Design

State-of-the-Art Review

Authors

PWPaulina Wejner-Mik HMHector I Michelena KMKatarzyna Mizia-Stec

Discussion

Member takes

Overview

Prompts detailed echo/ECG phenotyping to stratify SCD risk in MVP; extends recognition of this heterogeneous syndrome beyond isolated prolapse.

Key Points

Ventricular arrhythmias are a significant risk in mitral valve prolapse, especially in a subset of patients.
Research shows that arrhythmic risk remains post-surgery for mitral regurgitation due to existing myocardial substrate.
Clinical characteristics, like mitral annular disjunction and myocardial fibrosis, are key indicators of arrhythmogenic MVP.
Registry data emphasize the need for detailed echocardiographic evaluation to identify true arrhythmogenic MVP cases.

Structured PICO

Population

Patients with mitral valve prolapse (MVP) and arrhythmogenic MVP

Cite This Study

Wejner-Mik et al. (2026) studied this question.

synapsesocial.com/papers/69a75b95c6e9836116a23210 https://doi.org/10.33963/v.phj.110914

View Full Paper

Ask AI

Bookmark